Compared with patients with SSc without PAH and those with idiopathic PAH, patients with SSc with PAH had higher levels of serum IL-32, suggesting IL-32 as a promising biomarker for detecting PAH in patients with SSc (16). This evidence concerns the gene IL32 and pulmonary arterial hypertension.